VEVRX | VMVAX | VEVRX / VMVAX | |
Total Expense Ratio | 0.54 | 0.07 | 771% |
Annual Report Gross Expense Ratio | 0.54 | 0.07 | 771% |
Fund Existence | 11 years | 14 years | - |
Gain YTD | 1.210 | 5.198 | 23% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.2B | 31B | 55% |
Annual Yield % from dividends | 1.18 | 2.22 | 53% |
Returns for 1 year | -7.07 | 7.67 | -92% |
Returns for 3 years | -2.43 | 17.51 | -14% |
Returns for 5 years | 35.47 | 65.15 | 54% |
Returns for 10 years | 46.32 | 87.87 | 53% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MVFG | 29.38 | 0.14 | +0.47% |
Monarch Volume Factor Gbl Uncons ETF | |||
LEMB | 40.68 | 0.13 | +0.32% |
iShares JP Morgan EM Local Ccy Bd ETF | |||
PTY | 13.95 | -0.03 | -0.21% |
PIMCO Corporate & Income Opportunity Fund | |||
EPV | 25.28 | -0.06 | -0.24% |
ProShares UltraShort FTSE Europe | |||
FGSM | 28.21 | -0.07 | -0.26% |
Frontier Asset Global Small-Cap Equity ETF |